Heather O’Leary

Dr. Heather O’Leary


Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 November 2012 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
HBHal E Broxmeyer
Hal E Broxmeyer
JHJonathan Hoggatt
Jonathan Hoggatt
HOHeather O’Leary
Heather O’Leary
CMCharlie Mantel
Charlie Mantel
BCBrahmananda R Chitteti
Brahmananda R Chitteti
TCTimothy B Campbell
Timothy B Campbell

15 March 2010 in PLOS ONE
Verified
Journal Article
Open access
PDF file
Fariba RezaeeFariba Rezaee
Fariba Rezaee
SRStephanie L. Rellick
Stephanie L. Rellick
GPGiovanni Piedimonte
Giovanni Piedimonte
SAStephen M. Akers
Stephen M. Akers
HOHeather O’Leary
Heather O’Leary
LGLaura F. Gibson
Laura F. Gibson
The host's response to infection is characterized by altered levels of neurotrophins and an influx of inflammatory cells to sites of injured tissue. Progenitor cells that give rise to the differentiated cellular mediators of inflammation are derived from bone marrow progenitor cells where their development is regulated, in part, by cues from bone marrow stromal cells (BMSC). As such, alteration of BMSC function in response to elevated systemic mediators has the potential to alter their function in biologically relevant ways, including downstream alteration of cytokine production that influences hematopoietic development. In the current study we investigated BMSC neurotrophin receptor expression by flow cytometric analysis to determine differences in expression as well as potential to respond to NGF or BDNF. Intracellular signaling subsequent to neurotrophin stimulation of BMSC was analyzed by western blot, microarray analysis, confocal microscopy and real-time PCR. Analysis of BMSC Interleukin-6 (IL-6) expression was completed using ELISA and real-time PCR. BMSC established from different individuals had distinct expression profiles of the neurotrophin receptors, TrkA, TrkB, TrkC, and p75NTR. These receptors were functional, demonstrated by an increase in Akt-phosphorylation following BMSC exposure to recombinant NGF or BDNF. Neurotrophin stimulation of BMSC resulted in increased IL-6 gene and protein expression which required activation of ERK and p38 MAPK signaling, but was not mediated by the NFκB pathway. BMSC response to neurotrophins, including the up-regulation of IL-6, may alter their support of hematopoiesis and regulate the availability of inflammatory cells for migration to sites of injury or infection. As such, these studies are relevant to the growing appreciation of the interplay between neurotropic mediators and the regulation of hematopoiesis.

1 November 2007 in Blood
Verified
Journal Article
Closed access
PDF file
LWLin Wang
Lin Wang
HOHeather O’Leary
Heather O’Leary
JFJames Fortney
James Fortney
LGLaura F. Gibson
Laura F. Gibson
Although leukemic stem cells (LSCs) show a symbiotic relationship with bone marrow microenvironmental niches, the mechanism by which the marrow microenvironment contributes to self-renewal and proliferation of LSCs remains elusive. In the present study, we identified a unique subpopulation of Philadelphia chromosome–positive (Ph+) acute lymphoblastic leukemia (ALL) cells coexpressing markers of endothelial cells (including VE-cadherin, PECAM-1, and Flk-1) and committed B-lineage progenitors. After long-term coculture with bone marrow stromal cells, tumor cells formed hematopoietic colonies and cords, expressed early stem- cell markers, and showed endothelial sprouting. Gene expression profiles of LSCs were altered in the presence of stromal cell contact. Stromal cell contact promoted leukemic cell VE-cadherin expression, stabilized β-catenin, and up-regulated Bcr-abl fusion gene expression. Our study indicates that these specific tumor cells are uniquely positioned to respond to microenvironment-derived self-renewing and proliferative cues. Ph+/VE-cadherin+ tumor subpopulation circumvents the requirement of exogenous Wnt signaling for self-renewal through stromal cell support of leukemic cell VE-cadherin expression and up-regulated Bcr-abl tyrosine kinase activity. These data suggest that strategies targeting signals in the marrow microenvironment that amplify the Bcr-abl/VE-cadherin/β-catenin axis may have utility in sensitizing drug-resistant leukemic stem cells.

1 July 2013 in Current Opinion in Hematology
Verified
Journal Article
Closed access
HOHeather O’Leary
Heather O’Leary
XOXuan Ou
Xuan Ou
HBHal E. Broxmeyer
Hal E. Broxmeyer
Purpose of review Dipeptidyl peptidase 4 (DPP4, CD26) is a protease that cleaves selected amino acids at the N-terminal penultimate position and has the potential to alter the protein function. The regulation and roles of DPP4 activity are not well understood; therefore, the purpose of this review is to discuss the recent literature regarding DPP4 regulation, as well as the variety of molecules it may affect, and their potential clinical applications. Recent findings Recent insight into the number of proteins that have DPP4 sites, and how DPP4 truncation may alter hematopoiesis based on the protein full length vs. truncated state, has shown that DPP4 truncation of colony-stimulating factors (CSFs) alters their function and that the activity of these CSFs can be enhanced when DPP4 activity is inhibited. DPP4 inhibition has recently been used in a clinical trial to attempt to enhance the engraftment of cord blood cells, and an endogenous DPP4 inhibitor tissue factor pathway inhibitor has been discovered, increasing our understanding of the potential importance of DPP4. Summary DPP4 plays a role in regulating the activity of CSFs and other cytokines involved in hematopoiesis. This information may be useful for enhancing hematopoietic cell transplantation, blood cell recovery after stress, and for understanding the physiology and pathophysiology of blood and other cell systems.

1 September 2010 in Experimental Hematology
Verified
Journal Article
Closed access
SAStephen M. Akers
Stephen M. Akers
HOHeather O’Leary
Heather O’Leary
FMFred L. Minnear
Fred L. Minnear
MCMichael D. Craig
Michael D. Craig
JVJeffrey A. Vos
Jeffrey A. Vos
LGLaura F. Gibson
Laura F. Gibson

1 August 2013 in Stem Cells
Verified
Journal Article
Closed access
PDF file
HBHal E. Broxmeyer
Hal E. Broxmeyer
NMNirit Mor-Vaknin
Nirit Mor-Vaknin
FKFerdinand Kappes
Ferdinand Kappes
MLMaureen Legendre
Maureen Legendre
ASAnjan K. Saha
Anjan K. Saha
DMDavid M. Markovitz
David M. Markovitz